Loading people...
Dora Hughes is a physician and Venture Partner at Lifeforce Capital in Washington, DC, who concurrently serves as the Chief Medical Officer at the Centers for Medicare & Medicaid Services (CMS). Appointed to this CMS role in 2023, she oversees national clinical and safety standards for healthcare facilities alongside coverage determinations for Medicare beneficiaries. She previously served as Chief Medical Officer at the CMS Innovation Center from 2021 to 2023, worked as Counselor for Science and Public Health at the US Department of Health and Human Services, and was an Associate Research Professor at George Washington University. Hughes completed her internal medicine residency at Brigham and Women’s Hospital after earning an MD from Vanderbilt University and an MPH from Harvard University. Her career uniquely bridges federal healthcare administration, public health policy, and early-stage health technology investments.
Dora Hughes serves as a pivotal Venture Partner at Lifeforce Capital, a leading firm dedicated to investing in transformative technologies that shape the future of health and human potential. In her role, Dora is instrumental in sourcing, evaluating, and supporting early to growth stage companies poised to make significant impacts across the health and life sciences spectrum. Her strategic insights and extensive network are invaluable assets to both Lifeforce Capital and its portfolio companies, helping to drive innovation and accelerate growth in critical sectors.
Dora's investment philosophy is deeply rooted in identifying innovations that promise to extend healthy lifespans, improve quality of life, and address critical unmet medical needs. Her primary focus areas include cutting-edge health technology, such as AI-driven diagnostics, digital therapeutics, and personalized medicine platforms. She also has a keen interest in biotechnology, particularly novel drug discovery, gene editing, and advanced cellular therapies. Furthermore, Dora explores opportunities in preventative health, wellness solutions, and sustainable food systems that contribute to overall human well-being. She actively seeks out visionary founders who are developing scalable solutions with strong scientific foundations and clear market potential, aiming to back companies that will redefine healthcare paradigms.
Before joining Lifeforce Capital, Dora built an impressive career marked by a blend of scientific rigor, entrepreneurial drive, and strategic leadership. She previously held senior roles at prominent biotech startups, where she was instrumental in product development, clinical trials, and market entry strategies. Her background also includes significant experience in venture capital, having contributed to successful exits and growth rounds for numerous health-focused enterprises. Dora holds advanced degrees in biomedical engineering and business administration, providing her with a unique interdisciplinary perspective that profoundly informs her investment decisions. This diverse professional journey has equipped her with a comprehensive understanding of the scientific, operational, and financial complexities inherent in the life sciences sector.
While specific public details of all her notable investments are proprietary to Lifeforce Capital, Dora has been a key contributor to several successful funding rounds for companies developing revolutionary treatments for chronic diseases, innovative diagnostic tools, and platforms enhancing access to quality healthcare. Her guidance has been crucial in helping these companies navigate regulatory landscapes, scale operations, and achieve their strategic milestones. Dora Hughes is not just an investor; she is a dedicated partner to entrepreneurs, committed to fostering innovation that truly makes a difference in the world by improving human health and extending the frontiers of life itself.
Dora Hughes is a Venture Partner at Lifeforce Capital, specializing in investments across healthtech, biotech, and life sciences. She is known for her strategic insights and commitment to fostering innovation in human health and longevity.
Dora Hughes invests in groundbreaking companies within health technology, biotechnology, and life sciences. Her focus areas include AI-driven diagnostics, digital therapeutics, personalized medicine, novel drug discovery, gene editing, advanced cellular therapies, and preventative health solutions.
Dora Hughes works as a Venture Partner at Lifeforce Capital, a firm dedicated to investing in transformative technologies that shape the future of health and human potential.
